Matthias Schuster

Former Vice President-Research at Epigenomics AG

Matthias Schuster

Matthias Schuster

Former Vice President-Research at Epigenomics AG

Overview
RelSci Relationships

76

Relationships
RelSci Relationships are individuals Matthias Schuster likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Clearbridge Biomedics Pte Ltd.

Relationship likelihood: Average

Managing Director at Apta Biosciences Ltd.

Relationship likelihood: Average

Former Professor at Yokohama City University

Relationship likelihood: Average

Former Associate Professor at University of Cologne

Relationship likelihood: Average

Former Chief Executive Officer at Dx assays Pte Ltd.

Relationship likelihood: Average

Former Scientist at Novartis Institute for Tropical Diseases Pte Ltd.

Relationship likelihood: Weak

Manager-Human Resources at Epigenomics AG

Relationship likelihood: Weak

Former Vice President-Business Development at ApoCell, Inc.

Relationship likelihood: Weak

Former Head-Marketing & Sales at Epigenomics AG

Relationship likelihood: Weak

Former Chief Commercial Officer at Epigenomics AG

Relationship likelihood: Weak

Paths to Matthias Schuster
Potential Connections via
Relationship Science
You
Matthias Schuster
Former Vice President-Research at Epigenomics AG
Career History
Scientific Director
2009 - Prior

Established in 2008, Dx assays is Singapore's first commercial developer of molecular assays. Their company specializes in Nucleic Acid-based Test (NAT) development. They offer highly customizable services in assay design, development and validation for client-provided content in areas such as infectious disease testing, assay integration and development of companion diagnostic assays.Its laboratories are equipped with the state-of-the-art technologies and are operated by highly qualified personnel under the compliance of ISO-13485 : 2003.

Vice President-Research
Prior

Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, and Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA. The comapny was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo Gut on April 30, 1997 and is headquartered in Berlin, Germany.

Professional
Prior

The Scripps Research Institute (TSRI), one of the world's largest, private, non-profit research organizations, stands at the forefront of basic biomedical science, a vital segment of medical research that seeks to comprehend the most fundamental processes of life. Over the last decades, the institute has established a lengthy track record of major contributions to the betterment of health and the human condition. The institute — which is located on campuses in La Jolla, California, and Jupiter, Florida — has become internationally recognized for its research into immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune diseases, cardiovascular diseases, virology, and synthetic vaccine development. Particularly significant is the institute's study of the basic structure and design of biological molecules; in this arena TSRI is among a handful of the world's leading centers. The institute’s educational programs are also top-rate. The Kellogg School of Science and Technology is currently ranked among the best in the nation in its fields of biology and chemistry. Rather than isolating faculty members, students, and laboratories into separate and distinct disciplines, as is generally prescribed in universities, a cooperative, collaborative spirit is encouraged and embraced. While the level of scientific investigation is intense, the atmosphere is collegial, relaxed, and informal. Technicians, postdoctoral fellows, graduate students, and administrative support staff all are considered part of the team and are given the latitude and responsibility to accomplish their tasks so as to serve the best interests of science. The pursuit of scientific excellence is paramount and all efforts are directed toward that end. The bulk of the institute's funding is derived from the National Institutes of Health and other federal agencies. In today's environment of increasing competition for shrinking federal dollars, however, collaborative industrial partnerships with leading pharmaceutical companies provide additional funding in several areas key to the organization's research objectives. The Scripps Research Institute's adherence to the highest scientific standards, emphasis on a multidisciplinary approach to problem solving, participation in the perpetuation of knowledge through education, and continual pursuit of research excellence provide an unparalleled scientific environment.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Matthias Schuster. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Matthias Schuster's profile does not indicate a business or promotional relationship of any kind between RelSci and Matthias Schuster.